Leaflet IRBESARTAN TERAPIA 150mg film-coated tablets

Indicated for: hypertension

Route of administration: oral

Substance: irbesartan (angiotensin II receptor blocker)

ATC: C09CA04 (Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain)

Precautions:
Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

Irbesartan is a medication used to treat high blood pressure and diabetic nephropathy in patients with type 2 diabetes. It belongs to the class of angiotensin II receptor antagonists and works by relaxing blood vessels, thereby lowering blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor.

Side effects may include dizziness, fatigue, nausea, or increased potassium levels in the blood. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.

General data about IRBESARTAN TERAPIA 150mg

  • Substance: irbesartan
  • Date of latest medicines list: 01-06-2026
  • Product code: W54081003
  • Concentration: 150mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: Generic medicine
  • Price: 23.66 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: TERAPIA SA - ROMANIA
  • Holder: TERAPIA S.A. - ROMANIA
  • Number: 6306/2014/03
  • Shelf life: 3 years

Pharmaceutical forms available for irbesartan

Concentrations available for irbesartan

  • 150mg
  • 300mg
  • 7.5mg
  • 75mg

Compensation lists for IRBESARTAN TERAPIA 150mg Terapia

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

23.66 RON

11.83 RON

11.83 RON

G25 (C1) - Chronic renal failure

Price

Copayment

Patient

23.66 RON

19.55 RON

4.11 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

23.66 RON

19.55 RON

4.11 RON